Found: 62
Select item for more details and to access through your institution.
Effectiveness of the Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters in Pregnant Persons Who Were Not Immunocompromised: VISION Network, June 2022–August 2023.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 9, p. 1, doi. 10.1093/ofid/ofae481
- By:
- Publication type:
- Article
Effectiveness of the Original Monovalent Coronavirus Disease 2019 Vaccines in Preventing Emergency Department or Urgent Care Encounters and Hospitalizations Among Adults With Disabilities: VISION Network, June 2021-September 2022.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 11, p. 1, doi. 10.1093/ofid/ofad474
- By:
- Publication type:
- Article
Effectiveness of Booster Doses of Monovalent mRNA COVID-19 Vaccine Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children, Adolescents, and Adults During Omicron Subvariant BA.2/BA.2.12.1 and BA.4/BA.5 Predominant Periods
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 5, p. 1, doi. 10.1093/ofid/ofad187
- By:
- Publication type:
- Article
Regional Variation in Outpatient Antibiotic Prescribing for Acute Respiratory Tract Infections in a Commercially Insured Population, United States, 2017.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 2, p. 1, doi. 10.1093/ofid/ofac584
- By:
- Publication type:
- Article
Characteristics of Intracranial Group A Streptococcal Infections in US Children, 1997–2014.
- Published in:
- Journal of the Pediatric Infectious Diseases Society, 2020, v. 9, n. 1, p. 30, doi. 10.1093/jpids/piy108
- By:
- Publication type:
- Article
Characteristics and Risk Factors of Hospitalized and Nonhospitalized COVID-19 Patients, Atlanta, Georgia, USA, March-April 2020.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Antibody Responses after Classroom Exposure to Teacher with Coronavirus Disease, March 2020.
- Published in:
- 2020
- By:
- Publication type:
- Case Study
Characteristics of Patients with Acute Flaccid Myelitis, United States, 2015-2018.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Streptococcus pneumoniae Serotype 15A in Psychiatric Unit, Rhode Island, USA, 2010-2011.
- Published in:
- Emerging Infectious Diseases, 2012, v. 18, n. 11, p. 1889, doi. 10.3201/eid1811.120454
- By:
- Publication type:
- Article
Risk of COVID‐19 Hospitalization and Protection Associated With mRNA Vaccination Among US Adults With Psychiatric Disorders.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 3, p. 1, doi. 10.1111/irv.13269
- By:
- Publication type:
- Article
Use of COVID-19 Vaccines for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices -United States, 2024–2025.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2024, v. 73, n. 37, p. 819, doi. 10.15585/mmwr.mm7337e2
- By:
- Publication type:
- Article
Use of an Additional Updated 2023--2024 COVID-19 Vaccine Dose for Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices -- United States, 2024.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2024, v. 73, n. 16, p. 377, doi. 10.15585/mmwr.mm7316a4
- By:
- Publication type:
- Article
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged =18 Years with Immunocompromising Conditions -- VISION Network, September 2023-February 2024.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2024, v. 73, n. 12, p. 271, doi. 10.15585/mmwr.mm7312a5
- By:
- Publication type:
- Article
Early Estimates of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults -- Increasing Community Access to Testing Program, United States, September 2023-January 2024
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2024, v. 73, n. 4, p. 77, doi. 10.15585/mmwr.mm7304a2
- By:
- Publication type:
- Article
Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing COVID-19-Related Thromboembolic Events Among Medicare Enrollees Aged ≥65 Years and Those with End Stage Renal Disease -- United States, September 2022-March 2023.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2024, v. 73, n. 1, p. 16, doi. 10.15585/mmwr.mm7301a4
- By:
- Publication type:
- Article
Use of Updated COVID-19 Vaccines 2023-2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices -- United States, September 2023.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2023, v. 72, n. 42, p. 1140, doi. 10.15585/mmwr.mm7242e1
- By:
- Publication type:
- Article
Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19--Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months--5 Years -- VISION Network, United States, July 2022--June 2023.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2023, v. 72, n. 33, p. 886, doi. 10.15585/mmwr.mm7233a2
- By:
- Publication type:
- Article
Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months — United States, April 2023.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2023, v. 72, n. 24, p. 657, doi. 10.15585/mmwr.mm7224a3
- By:
- Publication type:
- Article
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions -- VISION Network, September 2022-April 2023.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2023, v. 72, n. 21, p. 579, doi. 10.15585/mmwr.mm7221a3
- By:
- Publication type:
- Article
Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3-5 Years -- Increasing Community Access to Testing Program, United States, July 2022--February 2023.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2023, v. 72, n. 7, p. 177, doi. 10.15585/mmwr.mm7207a3
- By:
- Publication type:
- Article
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, December 2022–January 2023.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2023, v. 72, n. 5, p. 119, doi. 10.15585/mmwr.mm7205e1
- By:
- Publication type:
- Article
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection - Increasing Community Access to Testing Program, United States, September-November 2022.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines - United States, October 2022.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Public Health Response to a Case of Paralytic Poliomyelitis in an Unvaccinated Person and Detection of Poliovirus in Wastewater -- New York, June-August 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 33, p. 1065, doi. 10.15585/mmwr.mm7133e2
- By:
- Publication type:
- Article
Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years -- United States, June 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 26, p. 859, doi. 10.15585/mmwr.mm7126e2
- By:
- Publication type:
- Article
Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated -- VISION Network, 10 States, December 2021-June 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 29, p. 931
- By:
- Publication type:
- Article
Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant -- United States, February 14-March 27, 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 18, p. 633
- By:
- Publication type:
- Article
Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 13, p. 495, doi. 10.15585/mmwr.mm7113e2
- By:
- Publication type:
- Article
The Advisory Committee on Immunization Practices' Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines -- United States, February 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 11, p. 416, doi. 10.15585/mmwr.mm7111a4
- By:
- Publication type:
- Article
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Early COVID-19 First-Dose Vaccination Coverage Among Residents and Staff Members of Skilled Nursing Facilities Participating in the Pharmacy Partnership for Long-Term Care Program -- United States, December 2020-January 2021.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2021, v. 70, n. 5, p. 178, doi. 10.15585/mmwr.mm7005e2
- By:
- Publication type:
- Article
Limited Secondary Transmission of SARS-CoV-2 in Child Care Programs - Rhode Island, June 1-July 31, 2020.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Pneumococcal genome sequencing tracks a vaccine escape variant formed through a multi-fragment recombination event.
- Published in:
- Nature Genetics, 2012, v. 44, n. 3, p. 352, doi. 10.1038/ng.1072
- By:
- Publication type:
- Article
Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome in children.
- Published in:
- Pediatric Pulmonology, 2016, v. 51, n. 2, p. 157, doi. 10.1002/ppul.23221
- By:
- Publication type:
- Article
Geographic and Temporal Trends in Antimicrobial Nonsusceptibility in Streptococcus pneumoniae in the Post-vaccine era in the United States.
- Published in:
- Journal of Infectious Diseases, 2013, v. 208, n. 8, p. 1266, doi. 10.1093/infdis/jit315
- By:
- Publication type:
- Article
Effect of the 2009 Influenza A(H1N1) Pandemic on Invasive Pneumococcal Pneumonia.
- Published in:
- Journal of Infectious Diseases, 2013, v. 207, n. 7, p. 1135, doi. 10.1093/infdis/jit008
- By:
- Publication type:
- Article
The US Federal Retail Pharmacy Program: Optimizing COVID-19 Vaccine Delivery Through a Strategic Public–Private Partnership.
- Published in:
- Public Health Reports, 2023, v. 138, n. 6, p. 870, doi. 10.1177/00333549231186606
- By:
- Publication type:
- Article
Surveillance of COVID-19 Vaccination in Nursing Homes, United States, December 2020–July 2021.
- Published in:
- Public Health Reports, 2022, v. 137, n. 2, p. 239, doi. 10.1177/00333549211066168
- By:
- Publication type:
- Article
Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 3, p. e232598, doi. 10.1001/jamanetworkopen.2023.2598
- By:
- Publication type:
- Article
Infection Control Assessment of Ambulatory Surgical Centers.
- Published in:
- JAMA: Journal of the American Medical Association, 2010, v. 303, n. 22, p. 2273, doi. 10.1001/jama.2010.744
- By:
- Publication type:
- Article
Recombinant Zoster Vaccine (Shingrix): Real-World Effectiveness in the First 2 Years Post-Licensure.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 6, p. 941, doi. 10.1093/cid/ciab125
- By:
- Publication type:
- Article
Incidence of Pharyngitis, Sinusitis, Acute Otitis Media, and Outpatient Antibiotic Prescribing Preventable by Vaccination Against Group A Streptococcus in the United States.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 1, p. e47, doi. 10.1093/cid/ciaa529
- By:
- Publication type:
- Article
Breastfeeding Duration and Cytomegalovirus Seroprevalence Among US Children Aged 1–5 Years: The National Health and Nutrition Examination Surveys, 2011–2012 and 2017–2018.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Long-term Protection Associated With COVID-19 Vaccination and Prior Infection.
- Published in:
- JAMA: Journal of the American Medical Association, 2022, v. 328, n. 14, p. 1402, doi. 10.1001/jama.2022.14660
- By:
- Publication type:
- Article
Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance.
- Published in:
- JAMA: Journal of the American Medical Association, 2022, v. 327, n. 22, p. 2210, doi. 10.1001/jama.2022.7493
- By:
- Publication type:
- Article
First-Dose COVID-19 Vaccination Coverage Among Skilled Nursing Facility Residents and Staff.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Relative Effectiveness of Coronavirus Disease 2019 Vaccination and Booster Dose Combinations Among 18.9 Million Vaccinated Adults During the Early Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Period—United States, 1 January 2022 to 31 March 2022
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 10, p. 1753, doi. 10.1093/cid/ciad063
- By:
- Publication type:
- Article
Invasive Pneumococcal Disease and 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Coverage Among Children Aged ≤59 Months -- Selected U.S. Regions, 2010-2011.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2011, v. 60, n. 43, p. 1477
- By:
- Publication type:
- Article
Impact of the COVID-19 Vaccination Program on case incidence, emergency department visits, and hospital admissions among children aged 5–17 Years during the Delta and Omicron Periods—United States, December 2020 to April 2022.
- Published in:
- PLoS ONE, 2022, v. 17, n. 12, p. 1, doi. 10.1371/journal.pone.0276409
- By:
- Publication type:
- Article
Missed Opportunities: A National Survey of Obstetricians About Attitudes on Maternal and Infant Immunization.
- Published in:
- 2012
- By:
- Publication type:
- Report